Copy to clipboard 
GlobalMed Logistix (GMLx), a provider of specialized logistics for medical device manufacturers, announced a partnership with strategic healthcare investor Water Street Healthcare Partners. The partnership establishes GMLx as an independent company and provides significant capital to drive the company’s next phase of growth. GMLx also announced the appointment of Patrick Daly, a longtime medical technology leader, as chief executive officer.
The new partnership marks a pivotal milestone for GMLx, which has built a strong foundation through its heritage with founder CrossLink LifeSciences. As medical device manufacturers face mounting logistical and compliance requirements amid rising cost pressures, GMLx has grown to serve global medtech leaders and entrepreneurial businesses seeking specialized logistics solutions. GMLx addresses these industry challenges through a suite of solutions encompassing inventory management, surgical tray and kit assembly, warehousing, reverse logistics, and quality control services, as well as tissue storage and distribution.
“GMLx serves as the essential logistics backbone for our OEM partners, managing complex protocols to help ensure our clients’ medical devices arrive exactly where and when patients need them. There is zero margin for error in surgical logistics. Speed, reliability, compliance, and scalability are critical, and these are the areas where we excel,” said Scott Vane, GMLx President and Chief Operating Officer, who will continue leading operations alongside Hunter Fleetwood, Head of Sales.
He added, “With Water Street’s support, we plan to further expand our services and national reach to help more medical technology companies achieve operational velocity in the high-stakes surgical environment.”
To spearhead the next phase of GMLx’s expansion, the company has appointed Patrick Daly to join its leadership team as CEO. Mr. Daly brings more than 30 years of global leadership experience across medtech and life sciences, spanning entrepreneurial ventures and Fortune 500 businesses. He was president and CEO of Cohera Medical, Inc. and most recently served as chief business officer for Terumo Blood and Cell Technologies. Previously, he led IQVIA’s Global MedTech Data franchise and held senior leadership positions with Johnson & Johnson across the U.S. and Asia Pacific. Mr. Daly also served on the executive board of The Advanced Medical Technology Association, and as chairman of AdvaMed Accel.
Water Street has committed significant capital to advance the next phase of GMLx’s expansion. Its strategic investment will enable GMLx to broaden its solution portfolio, accelerate breakthrough innovation, and extend its national footprint as an industry-wide partner for all medical device manufacturers navigating today’s challenging surgical care environment.
Industry veteran Camille Farhat will join the board of directors as chairman. He brings decades of medical technology experience from global organizations including Baxter International, GE Healthcare, and Medtronic, and currently serves as an executive advisor with Water Street.
Source: GlobalMed Logistix
